![[feed]](http://eprints.gla.ac.uk/style/images/feed-icon-14x14.png){kind=icon}
![[feed]](http://eprints.gla.ac.uk/style/images/twitter-logo.png){kind=logo}
Mix, TCH et al. (2005) Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal, 149 . pp. 408-413. (doi:10.7016/j.ahj.2004.09.047)
Full text not currently available from Enlighten.
| Item Type: | Article |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s): | McMurray, Prof John |
| Authors: | Mix, TCH, Brenner, RM, Cooper, ME, de Zeeuw, D, Ivanovich, P, Levey, AS, McGill, JB, McMurray, JJV, Parfrey, PS, Parving, HH, Pereira, BJG, Remuzzi, G, Singh, AK, Solomon, SD, Stehman-Breen, C, Toto, RD, and Pfeffer, MA |
| College/School: | College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences College of Medical Veterinary and Life Sciences |
| Journal Name: | American Heart Journal |
University Staff: Request a correction | Enlighten Editors: Update this record
Tools
Tools